In both cases, robust tumor formation was observed, demonstrating that the N2G model effectively supports the engraftment of diverse human cancer cell types, including HER2-positive and triple-negative breast cancer cells. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.